WHO ICTRP trial
Multicentre Cancer Chemotherapy Group Randomised Trial of Adjuvant Chemotherapy…
ISRCTN92329652 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN92329652 |
|---|---|
| Public title | Multicentre Cancer Chemotherapy Group Randomised Trial of Adjuvant Chemotherapy for 'Early' Breast Cancer |
| Scientific title | Multicentre Cancer Chemotherapy Group Randomised Trial of Adjuvant Chemotherapy for 'Early' Breast Cancer |
| Primary sponsor | Action Cancer Belfast (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | United Kingdom |
| Conditions | Breast cancer Cancer Breast cancer |
| Interventions | Following initial local therapy, surgery with or without radiotherapy, patients are randomised to one of 2 treatment arms: 1. Arm A: Tamoxifen 10 mg twice daily for 12 months. 2. Arm B: A total of eight cycles of multidrug chemotherapy… |
| Registration date | Aug 19, 2002 |
| Target size | 0 |
| Secondary IDs | B27 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: